Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥6,680 JPY
Change Today +10.00 / 0.15%
Volume 741.1K
6869 On Other Exchanges
As of 2:00 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

sysmex corp (6869) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/8/15 - ¥7,250
52 Week Low
04/28/14 - ¥3,140
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SYSMEX CORP (6869)

Related News

No related news articles were found.

sysmex corp (6869) Related Businessweek News

No Related Businessweek News Found

sysmex corp (6869) Details

Sysmex Corporation, together with its subsidiaries, engages in the research and development, production, sale, service, and support of diagnostic instruments, reagents, and software worldwide. The company provides diagnostics products for use in the areas of hematology, hemostasis, immunochemistry, clinical chemistry, urinalysis, and others; and La-vietal LS, a clinical testing instrument system that links clinical testing instruments and other systems to provide an efficient operating environment. It also offers particle analyzer products, including FPIA-3000 Flow Particle Image Analyzer, which offers automated analysis of particle size and shape; FPIA-3000 Darkfield unit to analyze samples, such as drugs, mica, and biological cells; and XT-2000iV, an animal blood cell analysis software used in the hematological analysis of laboratory veterinary animals, such as rats, mice, or dogs. In addition, the company provides life sciences solutions comprising automated gene amplification detector, a system for the detection of lymph node metastasis based on the one-step nucleic acid amplification method used for the diagnosis of breast, colon, and stomach cancer lymph node diagnosis in hospitals and other facilities, as well as a laboratory testing service for research involving the risk of recurrence of breast cancer. Further, it offers ASTRIM FIT, a peripheral artery monitoring device that measures hemoglobin levels without blood sampling and is used in fitness centers and various other sites, as well as sells health management support software. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

5,401 Employees
Last Reported Date: 06/20/14
Founded in 1968

sysmex corp (6869) Top Compensated Officers

Chairman of the Managing Board, Chief Executi...
Total Annual Compensation: ¥139.0M
Compensation as of Fiscal Year 2014.

sysmex corp (6869) Key Developments

Sysmex Signs Agreement with Cambodia's Ministry of Health Related to Scientific Support Activities Aimed At Enhancing the Quality of Clinical Testing

Sysmex Corporation announced that it had signed an agreement with Cambodia's Ministry of Health in relation to scientific support activities aimed at enhancing the quality of clinical testing in Cambodia. In accordance with this trend, Sysmex has entered into an agreement with Cambodia's Ministry of Health in relation to scientific support activities aimed at increasing the quality of clinical testing in Cambodia. Under this agreement, Sysmex will provide operational and maintenance support based on international standards for the Company's automated hematology analyzers that have been delivered to a standard laboratory1 certified by Cambodia's Ministry of Health. In addition, Sysmex will support the configuration and operation of an external quality control2 scheme in the hematology field for clinical laboratories in Cambodia. Furthermore, Sysmex will provide technological and scientific expertise based on the experience it has cultivated in global support services to the local healthcare professionals who are central to laboratory operation. Going forward, Sysmex will continue striving to provide support for clinical testing in developing countries and emerging markets, contributing to increased quality and standardization of clinical testing and thereby providing peace of mind to customers throughout the world.

Sysmex to Establish the Global Communication Center in Okuike, Ashiya, Hyogo Prefecture

Sysmex Corp. announced its intention to open the Global Communication Center in Okuike, Ashiya, Hyogo Prefecture, in April 2015 as a place to encourage further growth by facilitating unfettered communication and prompting ideas. The Global Communication Center aims to stimulate the free expression of ideas and encourage open communication through conversation, dialogue and discussion; and the center is equipped with various facilities with these goals in mind.

Sysmex Corp. Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2014; Provides Earnings Guidance for the Year Ending March 31, 2015; Provides Year End Dividend Guidance for the Year Ending March 31, 2015

Sysmex Corporation reported consolidated earnings results for the nine months ended December 31, 2014. For the period, the company reported net sales of JPY 155,852 million, operating income of JPY 31,517 million, ordinary income of JPY 33,137 million and net income of JPY 20,620 million or JPY 99.18 diluted per share as compared to net sales of JPY 129,849 million, operating income of JPY 22,123 million, ordinary income of JPY 23,159 million and net income of JPY 14,002 million or JPY 67.50 diluted per share for the same period a year ago. Income before income taxes and minority interest was JPY 33,087 million compared to JPY 22,936 million a year ago. Net cash provided by operating activities was JPY 24,111 million compared to JPY 22,270 million a year ago. Purchase of property, plant and equipment was JPY 9,897 million compared to JPY 9,109 million a year ago. Purchase of intangible assets was JPY 2,323 million compared to JPY 2,652 million a year ago. The company provided earnings guidance for the year ending March 31, 2015. For the year, the company expects net sales of JPY 210,000 million, operating income of JPY 41,000 million, ordinary income of JPY 40,700 million and net income of JPY 24,900 million or JPY 120.12 per share. For the year ending March 31, 2015, the company expects to pay year end dividend of JPY 16.00 per share compared to JPY 33.00 per share for the same period last year.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
6869:JP ¥6,680.00 JPY +10.00

6869 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $49.97 USD -0.04
Bio-Rad Laboratories Inc $137.41 USD +0.01
BioMerieux €98.06 EUR +0.84
Mindray Medical International Ltd $30.95 USD +0.07
PerkinElmer Inc $51.65 USD +0.08
View Industry Companies

Industry Analysis


Industry Average

Valuation 6869 Industry Range
Price/Earnings 51.1x
Price/Sales 6.6x
Price/Book 8.3x
Price/Cash Flow 46.0x
TEV/Sales 6.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYSMEX CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at